BB Biotech AG - CE with IsEquityFund

XSWX:BION (Switzerland) Ā  CE with IsEquityFundamentalDataAvailable = 1 in Gid
CHF 38.80 (-0.89%) Jun 18
11.48
P/B:
1.43
Market Cap:
CHF 2.13B ($ 2.41B)
Enterprise V:
CHF 2.47B ($ 2.80B)
Volume:
93.92K
Avg Vol (2M):
67.64K
Trade In:
Volume:
93.92K

Business Description

BB Biotech AG
NAICS : 325414
ISIN : CH0038389992

Share Class Description:

XSWX:BION: CE with IsEquityFundamentalDataAvailable = 1 in Gid
Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of theĀ investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.
Name Current Vs Industry Vs History
Equity-to-Asset 0.88
Debt-to-Equity 0.14
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate -5.6
3-Year Book Growth Rate -15.5
Name Current Vs Industry Vs History
5-Day RSI 24.17
9-Day RSI 31.07
14-Day RSI 34.1
6-1 Month Momentum % 0.97
12-1 Month Momentum % -2.46

Liquidity Ratio

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-07-19 Est.)

XSWX:BION's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return % Ā 

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return % Ā 

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BB Biotech AG Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 328.058
EPS (TTM) (CHF) 5.61
Beta 1.01
Volatility % 29.95
14-Day RSI 34.1
14-Day ATR (CHF) 0.732643
20-Day SMA (CHF) 40.0875
12-1 Month Momentum % -2.46
52-Week Range (CHF) 35.35 - 49.8
Shares Outstanding (Mil) 54.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BB Biotech AG Filings

Filing Date Document Date Form
No Filing Data

BB Biotech AG Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

BB Biotech AG Frequently Asked Questions

What is BB Biotech AG(XSWX:BION)'s stock price today?
The current price of XSWX:BION is CHF38.80. The 52 week high of XSWX:BION is CHF49.80 and 52 week low is CHF35.35.
When is next earnings date of BB Biotech AG(XSWX:BION)?
The next earnings date of BB Biotech AG(XSWX:BION) is 2024-07-19 Est..
Does BB Biotech AG(XSWX:BION) pay dividends? If so, how much?
TheĀ  Dividend Yield % Ā of BB Biotech AG(XSWX:BION) is 5.15% (As of Today), HighestĀ Dividend Payout RatioĀ of BB Biotech AG(XSWX:BION) was 0.36. The lowest was 0. And the median was 0. The Ā Forward Dividend Yield % of BB Biotech AG(XSWX:BION) is 5.15%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release